Plasmid DNAs encoding insulin and glutamic acid decarboxylase 65 have distinct effects on the progression of autoimmune diabetes in nonobese diabetic mice

被引:56
作者
Weaver, DJ [1 ]
Liu, B [1 ]
Tisch, R [1 ]
机构
[1] Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA
关键词
D O I
10.4049/jimmunol.167.1.586
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We previously demonstrated that administration of plasmid DNAs (pDNAs) encoding IL-4 and a fragment of glutamic acid decarboxylase 65 (GAD65) fused to IgGFc induces GAD65-specific Th2 cells and prevents insulin-dependent diabetes mellitus (IDDM) in nonobese diabetic (NOD) mice. To assess the general applicability of pDNA vaccination to mediate Ag-specific immune deviation, we examined the immunotherapeutic efficacy of recombinants encoding murine insulin A and B chains fused to IgGFc. Insulin was chosen based on studies demonstrating that administration of insulin or insulin B chain by a variety of strategies prevents IDDM in NOD mice. Surprisingly, young NOD mice receiving i.m. injections of pDNA encoding insulin B chain-IgGFc with or without IL-4 exhibited an accelerated progression of insulitis and developed early diabetes. Exacerbation of IDDM correlated with an increased frequency of WN-gamma -secreting CD4(+) and CD8(+) T cells in response to insulin B chain-specific peptides compared with untreated mice. In contrast, treatment with pDNAs encoding insulin A chain-IgGFc and IL-4 elicited a low frequency of IL-4-secreting Th cells and had no effect on the progression of IDDM. Vaccination with pDNAs encoding GAD65-specific and IL-4, however, prevented IDDM. These results demonstrate that insulin- and GAD65-specific T cell reactivity induced by pDNA vaccination has distinct effects on the progression of IDDM. The Journal of Immunology, 2001.
引用
收藏
页码:586 / 592
页数:7
相关论文
共 53 条
[1]   Dual overlapping peptides recognized by insulin peptide B:9-23 T cell receptor AV13S3 T cell clones of the NOD mouse [J].
Abiru, N ;
Wegmann, D ;
Kawasaki, E ;
Gottlieb, P ;
Simone, E ;
Eisenbarth, GS .
JOURNAL OF AUTOIMMUNITY, 2000, 14 (03) :231-237
[2]   Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein [J].
Brocke, S ;
Gijbels, K ;
Allegretta, M ;
Ferber, I ;
Piercy, C ;
Blankenstein, T ;
Martin, R ;
Utz, U ;
Karin, N ;
Mitchell, D ;
Veromaa, T ;
Waisman, A ;
Gaur, A ;
Conlon, P ;
Ling, N ;
Fairchild, PJ ;
Wraith, DC ;
OGarra, A ;
Fathman, CG ;
Steinman, L .
NATURE, 1996, 379 (6563) :343-346
[3]   Biolistic-mediated interleukin 4 gene transfer prevents the onset of type 1 diabetes [J].
Cameron, MJ ;
Strathdee, CA ;
Holmes, KD ;
Arreaza, GA ;
Dekaban, GA ;
Delovitch, TL .
HUMAN GENE THERAPY, 2000, 11 (12) :1647-1656
[4]   CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity [J].
Chu, RS ;
Targoni, OS ;
Krieg, AM ;
Lehmann, PV ;
Harding, CV .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (10) :1623-1631
[5]   Induction of TH1 and TH2 CD4+ T cell responses: The alternative approaches [J].
Constant, SL ;
Bottomly, K .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :297-322
[6]   DNA immunization to prevent autoimmune diabetes [J].
Coon, B ;
An, LL ;
Whitton, JL ;
von Herrath, MG .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (02) :189-194
[7]  
DANIEL D, 1995, EUR J IMMUNOL, V25, P1056, DOI 10.1002/eji.1830250430
[8]   Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23) [J].
Daniel, D ;
Wegmann, DR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (02) :956-960
[9]  
Degermann S, 1996, J IMMUNOL, V157, P3260
[10]   DNA vaccines [J].
Donnelly, JJ ;
Ulmer, JB ;
Shiver, JW ;
Liu, MA .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :617-648